Scientists around the world are achieving significant advances in the fight against devastating diseases like cancer, severe combined immunodeficiency (SCID) disorder and amyotrophic lateral sclerosis (ALS) thanks to leading-edge cell- and gene-based therapies. But numerous obstacles to progress could slow down those advances including insufficient evidence of effectiveness and market-driven economic uncertainties.

To continue reading this story, click here.